A definition of a pharmacophore for the 5-HT4 antagonist was carried out by considering a three-dimensionalmodel which correlates the chemical structures of series of antagonists with their biological affinities. Amolecular design is described by analyzing the differences between two 3D serotonin pharmacophores.This successful structural modification demonstrates the efficiency of this approach to design new serotoninligands.
